Advanced Carotid Plaque Imaging

European Journal of Vascular and Endovascular Surgery

Volumn 39, Issue 2, 2010, Pages 125-133

  Hermus, L ^a   van Dam, G M ^a   Zeebregts, C J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Atherosclerosis; Carotid artery; Molecular imaging; Near infrared fluorescence; Vulnerable plaque

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINE 125; LIPOCORTIN 5; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NANOPARTICLE;

ANGIOGENESIS; APOPTOSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; FLUORESCENCE ANALYSIS; HUMAN; INFLAMMATION; LIPID STORAGE; NEAR INFRARED FLUORESCENCE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN DEGRADATION; RABBIT; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THROMBOSIS;

APOPTOSIS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CAROTID STENOSIS; CEREBROVASCULAR DISORDERS; CONTRAST MEDIA; DIAGNOSTIC IMAGING; HUMANS; INFLAMMATION; PEPTIDE HYDROLASES; RADIOPHARMACEUTICALS;

EID: 76549085921     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2009.11.020     Document Type: Review

References (53)

1. World Health Organization (WHO). The atlas of heart disease and stroke. http://www.who.int/cardiovascular_diseases/en/cvd_atlas_16_death_from_stroke.pdf.
2. Adams H.P., Bendixen B.H., Kapelle L.J., Biller J., Love B.B., Gordon D.L., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of ORG 10172 in acute stroke treatment. Stroke 24 1 (1993) 35-41
3. van der Vaart M.G., Meerwaldt R., Reijnen M.M., Tio R.A., and Zeebregts C.J. Endarterectomy or carotid artery stenting: the quest continues. Am J Surg 195 2 (2008) 259-269
4. Lovett J.K., Gallagher P.J., Hands L.J., Walton J., and Rothwell P.M. Histological correlates of carotid plaque surface morphology on lumen contrast imaging. Circulation 110 15 (2004) 2190-2197
5. O'Donnell Jr. T.F., Erdoes L., Mackey W.C., McCullough J., Shepard A., Heggerick P., et al. Correlation of B-mode ultrasound scan imaging and arteriography with pathologic findings at carotid endarterectomy. Arch Surg 120 4 (1985) 443-449
6. Denzel C., Balzer K., Muller K.M., Fellner F., Fellner C., and Lang W. Relative value of normalized sonographic in vitro analysis of arteriosclerotic plaques of internal carotid artery. Stroke 34 8 (2003) 1901-1906
7. Reiter M., Horvat R., Puchner S., Rinner W., Polterauer P., Lammer J., et al. Plaque imaging of the internal carotid artery - correlation of B-flow imaging with histopathology. AJNR Am J Neuroradiol 28 1 (2007) 122-126
8. Wintermark M., Jawadi S.S., Rapp J.H., Tihan T., Tong E., Glidden D.V., et al. High resolution CT imaging of carotid artery atherosclerotic plaques. AJNR Am J Neuroradiol 29 5 (2008) 875-882
9. Das M., Braunschweig T., Mühlenbruch G., Mahnken A.H., Krings T., Langer S., et al. Carotid plaque analysis: comparison of dual-source computed tomography (CT) findings and histopathological correlation. Eur J Vasc Endovasc Surg 38 1 (2009) 14-19
10. U-King-Im J.M., Tang T.Y., Patterson A., Graves M.J., Howarth S., Li Z.Y., et al. Characterization of carotid atheroma in symptomatic and asymptomatic patients using high-resolution MRI. J Neurol Neurosurg Psychiatr 79 8 (2008) 905-912
11. Sadat U., Weerakkody R.A., Bowden D.J., Young V.E., Graves M.J., Li Z.Y., et al. Utility of high resolution MR imaging to assess carotid plaque morphology: a comparison of acute symptomatic, recently symptomatic and asymptomatic patients with carotid artery disease. Atherosclerosis 207 2 (2009) 434-439
12. Van der Vaart M.G., Meerwaldt R., Slart R.H., van Dam G.M., Tio R.A., and Zeebregts C.J. Application of PET/SPECT imaging in vascular disease. Eur J Vasc Endovasc Surg 35 5 (2008) 507-513
13. 18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. Semin Nucl Med 32 1 (2002) 70-76
14. 18F]-fluorodeoxyglucose positron emission tomography. Circulation 105 23 (2002) 2708-2711
15. 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 48 9 (2006) 1818-1824
16. Graebe M., Pedersen S.F., Borgwardt L., Højgaard L., Sillesen H., and Kjaer A. Molecular pathology in vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET). Eur J Vasc Surg 37 6 (2009) 714-721
17. 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke 36 12 (2005) 2642-2647
18. Rousset O.G., Ma Y., and Evans A.C. Correction for partial volume effects in PET: principle and validation. J Nucl Med 39 5 (1998) 904-911
19. Davies J.R., Rudd J.H., and Weissberg P.L. Molecular and metabolic imaging of atherosclerosis. J Nucl Med 45 11 (2004) 1898-1907
20. Izquierdo-Garcia D., Davies J.R., Graves M.J., Rudd J.H., Gillard J.H., Weissberg P.L., et al. Comparison of methods for magnetic resonance-guided [18-F]fluorodeoxyglucose positron emission tomography in human carotid arteries: reproducibility, partial volume correction, and correlation between methods. Stroke 40 1 (2009) 86-93
21. Patlak C.S., and Blasberg R.G. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 5 4 (1985) 584-590
22. 99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques. Eur J Nucl Med Mol Imaging 33 2 (2006) 117-126
23. Ohtsuki K., Hayase M., Akashi K., Kopiwoda S., and Strauss H.W. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradiographic study. Circulation 104 2 (2001) 203-208
24. 131I-Ama monoclonal antibody in atherosclerotic rabbits. Nucl Med Biol 22 6 (1995) 693-697
25. Kelly K.A., Allport J.R., Tsourkas A., Shinde-Patil V.R., Josephson L., and Weissleder R. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ Res 96 3 (2005) 327-336
26. Nahrendorf M., Jaffer F.A., Kelly K.A., Sosnovik D.E., Aikawa E., Libby P., et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 114 14 (2006) 1504-1511
27. 99mTc-labeled low density lipoproteins. Arterioscler Thromb Vasc Biol 8 5 (1988) 461-470
28. Iuliano L., Signore A., Vallabajosula S., Colavita A.R., Camastra C., Ronga G., et al. Preparation and biodistribution of 99m technetium labelled oxidized LDL in man. Atherosclerosis 126 1 (1996 Sep 27) 131-141
29. Morgan A.R., Rerkasem K., Gallagher P.J., Zhang B., Morris G.E., Calder P.C., et al. Differences in matrix metalloproteinase-1 and matrix metalloproteinase-12 transcript levels among carotid atherosclerotic plaques with different histopathological characteristics. Stroke 35 6 (2004) 1310-1315
30. Loftus I.M., Naylor A.R., Goodall S., Crowther M., Jones L., Bell P.R., et al. Increased matrix metalloproteinase-9 activity in unstable carotid plaques: a potential role in acute plaque disruption. Stroke 31 1 (2000) 40-47
31. Schafers M., Riemann B., Kopka K., Breyholz H.J., Wagner S., Schäfers K.P., et al. Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo. Circulation 109 21 (2004) 2554-2559
32. Fujimoto S., Hartung D., Ohshima S., Edwards D.S., Zhou J., Yalamanchili P., et al. Molecular imaging of matrix metalloproteinases in atherosclerotic lesions: resolution with dietary modification and statin therapy. J Am Coll Cardiol 52 23 (2008) 1847-1857
33. Van der Wiele C., and Oltenfreiter R. Imaging probes targeting matrix metalloproteinases. Cancer Biother Radiopharm 21 5 (2006) 409-417
34. Deguchi J.O., Aikawa M., Tung C.H., Aikawa E., Kim D.E., Ntziachristos V., et al. Inflammation in atherosclerosis: visualizing matrix metallo proteinase action in macrophages in vivo. Circulation 114 1 (2006) 55-62
35. Chen J., Tung C.H., Mahmood U., Ntziachristos V., Gyurko R., Fishman M.C., et al. In vivo imaging of proteolytic activity in atherosclerosis. Circulation 105 23 (2002) 2766-2771
36. Wallis de Vries B.M., Hillebrands J.L., van Dam G.M., Tio R.A., de Jong J.S., Slart R.H.J.A., et al. Images in cardiovascular medicine. Multi-spectral near-infrared fluorescence molecular imaging of matrix metalloproteinases in a human carotid plaque using a MMP-sensitive activatable fluorescent probe. Circulation 119 20 (2009) e534-e536
37. Takaya N., Yuan C., Chu B., Saam T., Polissar N.L., Jarvik G.P., et al. Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study. Circulation 111 21 (2005) 2768-2775
38. Holm P.W., Slart R.H., Zeebregts C.J., Hillebrands J.L., and Tio R.A. Atherosclerotic plaque development and instability: a dual role for VEGF. Ann Med 41 4 (2009) 257-264
39. Slart R.H.J.A., Zeebregts C.J., and Tio R.A. Can nuclear medicine shed light on the dark side of angiogenesis in cardiovascular disease?. Nucl Med Commun 29 7 (2008) 585-587
40. Szabo Z., Speth R.C., Brown P.R., Kerenyi L., Kao P.F., Mathews W.B., et al. Use of positron emission tomography to study AT1 receptor regulation in vivo. J Am Soc Nephrol 12 7 (2001) 1350-1358
41. Nagengast W.B., de Vries E.G., Hospers G.A., Mulder N.H., de Jong J.R., Hollema H., et al. In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft. J Nucl Med 48 8 (2007) 1313-1319
42. 99mTc-HYNIC-VEGF. Eur J Nucl Med Mol Imaging 33 7 (2006) 841-848
43. Backer M.V., Levashova Z., Vimalkumar P., Jehning B.T., Claffey K., Blankenberg F.G., et al. Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF based probes. Nat Med 13 4 (2007) 504-509
44. Matter C.M., Schuler P.K., Alessi P., Meier P., Ricci R., Zhang D., et al. Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibronectin. Circ Res 95 12 (2004) 1225-1233
45. Libby P., and Theroux P. Pathophysiology of coronary artery disease. Circulation 111 25 (2005) 3481-3488
46. Kolodgie F.D., Petrov A., Virmani R., Narula N., Verjans J.W., Weber D.K., et al. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation 108 25 (2003) 3134-3139
47. Haider N., Hartung D., Fujimoto S., Petrov A., Kolodgie F.D., Virmani R., et al. Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis. J Nucl Cardiol 16 5 (2009) 753-762
48. Kietselaer B.L., Reutelingsperger C.P., Heidendal G.A., Daemen M.J., Mess W.H., Hofstra L., et al. Noninvasive detection of plaque instability with use of radiolabelled annexin A5 in patients with carotid artery stenosis. N Engl J Med 350 14 (2004) 1472-1473
49. Sayed S., Cockerill G.W., Torsney E., Poston R., Thompson M.M., and Loftus I.M. Elevated tissue expression of thrombomodulatory factors correlates with acute symptomatic carotid plaque phenotype. Eur J Vasc Endovasc Surg 38 1 (2009) 20-25
50. Spagnoli L.G., Mauriello A., Sangiorgi G., Fratoni S., Bonanno E., Schwartz R.S., et al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA 292 15 (2004) 1845-1852
51. Moody A.R., Murphy R.E., Morgan P.S., Martel A.L., Delay G.S., Allder S., et al. Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation 107 24 (2003) 3047-3052
52. Moody A.R., Allder S., Lennox G., Gladman J., and Fentem P. Direct magnetic resonance imaging of carotid artery thrombus in acute stroke. Lancet 353 9147 (1999) 122-123
53. Chu B., Kampschulte A., Ferguson M.S., Kerwin W.S., Yarnykh V.L., O'Brien K.D., et al. Hemorrhage in the atherosclerotic carotid plaque: a high-resolution MRI study. Stroke 35 5 (2004) 1079-1084